Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bader Sultan & Brothers is a Kuwait-based private healthcare company founded in 1960 that distributes and supports a broad portfolio of medical devices, diagnostics, pharmaceuticals, hospital supplies, and healthcare technology solutions. The company operates as a diversified commercial healthcare platform rather than a drug developer, serving public and private healthcare customers primarily in Kuwait and also across Saudi Arabia and the UAE. Its business spans specialized divisions in pharmaceuticals, diagnostic imaging and therapy, genetics and genomics, cardiology, surgery, digital health, technical support, and laboratory solutions. BSBC also provides turnkey projects, equipment installation, maintenance, and technical support, and has been involved in nuclear medicine infrastructure including PET agent production and cyclotron-related capabilities. The company appears to function mainly as a distributor, systems integrator, and healthcare solutions provider partnering with multinational medical technology and pharmaceutical companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bader Sultan & Brothers.